Replies to post #486 on Halozyme Therapeutics Inc (HALO)

[rod5247]

I had to open my BIG mouth about the volume. :0

Although from different methods, someone agrees with my targets.

"Halozyme Therapeutics (HALO)
Halozyme Therapeutics (HALO:halozyme therapeutics inc com
News, chart, profile, more
Last: 7.86-0.01-0.13%

1:20pm 07/17/2008

Delayed quote dataAdd to portfolio
Analyst
Create alertInsider
Discuss
Financials
Sponsored by:
HALO 7.86, -0.01, -0.1%) , our next biotech buy, had a very strong surge late in 2006 when it exploded on a breakaway gap on heavy volume in December of that year and doubled quickly from the 4 area to around 8. A rising channel ensued, and the stock eventually made it up towards the 11 area before moving down for about an eight- to nine-month period, retesting that big breakaway gap about 14 months later.
After a strong surge in March and a pullback/retest by May, the stock made a higher low and formed a coiling-type pattern. It has now broken out of that pattern, taking out secondary resistance from the January and March highs to reach new 2008 highs.
Our immediate short-term target is around 8.5, with an intermediate-term target up towards the 11 area and long-term target in the mid-teens. Minor support is around 7, but much stronger intermediate support is in the 6-6.5 zone.
Halozyme develops and markets recombinant human enzymes for the drug delivery, palliative care, oncology, and infertility markets."

http://www.marketwatch.com/news/story/five-biotech-buys/story.aspx?guid=%7B5E7D93CE%2DC0EF%2D42C8%2DBB46%2D17A76E96FBBE%7D&siteid=yhoof